Structures by: Yogavel M.
Total: 32
C21H25F2N3O2
C21H25F2N3O2
Journal of medicinal chemistry (2018) 61, 13 5664-5678
a=7.5165(16)Å b=8.0959(17)Å c=24.661(9)Å
α=90° β=90° γ=90°
C32H40O10
C32H40O10
Journal of medicinal chemistry (2018) 61, 13 5664-5678
a=7.7904(6)Å b=11.4929(11)Å c=16.2869(15)Å
α=90° β=103.739(3)° γ=90°
CHO
CHO
Journal of medicinal chemistry (2018) 61, 13 5664-5678
a=6.9288(8)Å b=7.9172(9)Å c=52.844(6)Å
α=90° β=90° γ=90°
C16H20O5
C16H20O5
Journal of medicinal chemistry (2018) 61, 13 5664-5678
a=8.0784(3)Å b=8.0784(3)Å c=45.237(2)Å
α=90° β=90° γ=90°
{N,N-Bis[3-(phenylysulfanyl)-1-(phenylsulfonyl)indol-2- ylmethyl]amino}acetaldehyde dimethyl acetal
C46H41N3O6S4
Acta Crystallographica Section E (2005) 61, 10 o3205-o3207
a=10.71460(10)Å b=23.89390(10)Å c=16.8782(3)Å
α=90.00° β=91.8460(10)° γ=90.00°
2-methoxybenzaldehyde thiosemicarbazone
C9H11N3OS
Acta Crystallographica Section E (2002) 58, 12 o1336-o1338
a=13.5826(2)Å b=10.6063(2)Å c=14.3260(3)Å
α=90.00° β=90.00° γ=90.00°
8-Chloro-4-[1-(phenylsulfonyl)indol-3-yl]-3a,4,5,9b-tetrahydro-3H- cyclopenta[c]quinoline
C26H21ClN2O2S
Acta Crystallographica Section E (2003) 59, 1 o49-o51
a=15.0064(2)Å b=9.4052(2)Å c=15.7077(2)Å
α=90.00° β=91.0930(10)° γ=90.00°
2-Hydroxy-2-methyl-3-benzoylchromene
C17H14O3
Acta Crystallographica Section E (2003) 59, 3 o266-o268
a=5.691(4)Å b=6.902(3)Å c=34.044(2)Å
α=90.00° β=90.00° γ=90.00°
5-Amino-4-(4-dimethylaminophenyl)-2-(4-methoxyphenyl)-7-(pyrrolidin-1-yl)- 1,6-naphthyridine-8-carbonitrile
C28H28N6O
Acta Crystallographica Section E (2003) 59, 2 o200-o202
a=10.671(2)Å b=10.9740(10)Å c=11.826(2)Å
α=82.820(10)° β=64.040(10)° γ=78.320(10)°
2-cyano-3-dimethylamino-N-(2,5-methylphenyl)acrylamide
C14H17N3O
Acta Crystallographica Section E (2003) 59, 3 o353-o355
a=9.9315(2)Å b=11.8940(4)Å c=11.3979(4)Å
α=90.00° β=97.079(14)° γ=90.00°
2-Methoxy-4-acetamido-5-(3'-phenylthio indol-2-oyl)benzoic acid
C25H20N2O5S
Acta Crystallographica Section E (2003) 59, 5 o718-o720
a=10.8499(2)Å b=10.5171(2)Å c=19.0168(3)Å
α=90.00° β=92.1040(10)° γ=90.00°
3,3,6,6-Tetramethyl-9-(4-pyridyl)-3,4,6,7,9,10-hexahydro- 1,8(2H,5H)-acridinedione monohydrate
C22H26N2O2,H2O
Acta Crystallographica Section E (2003) 59, 5 o659-o661
a=9.1333(5)Å b=9.8999(5)Å c=12.0435(7)Å
α=74.8760(10)° β=81.7050(10)° γ=73.1370(10)°
1,2-Bis[1-phenylsulfonyl-3-(phenylthio)indol-2-yl]ethene
C42H30N2O4S4
Acta Crystallographica Section E (2003) 59, 1 o99-o101
a=9.2920(2)Å b=9.5524(3)Å c=11.3921(3)Å
α=67.3790(10)° β=72.8210(10)° γ=74.5890(10)°
5,5'-dimethyl-2-(4-methylphenylaminocarbomethyl)-1,3-cyclohexanedione
C17H21NO3
Acta Crystallographica Section E (2003) 59, 3 o261-o262
a=10.12390(10)Å b=5.83660(10)Å c=26.91760(10)Å
α=90.00° β=97.4030(10)° γ=90.00°
10-[2-(4-acetylpiperzain-1-yl)ethyl]-9-(4-chlorophenyl)-3,3,6,6-tetramethyl- 3,4,6,7,9,10-hexahydro-2H,5H-acridine-1,8-dione
C31H40ClN3O3
Acta Crystallographica Section E (2003) 59, 5 o696-o698
a=10.3624(6)Å b=21.4915(12)Å c=13.5314(8)Å
α=90.00° β=101.4920(10)° γ=90.00°
3-Acetyl-2-hydroxy-2-methylchromene
C12H12O3
Acta Crystallographica Section E (2003) 59, 5 o591-o593
a=7.574(2)Å b=8.672(2)Å c=8.789(3)Å
α=106.32(3)° β=110.99(3)° γ=93.28(3)°
2-[2-(4-Ethoxy-5-methoxy-2-nitrophenyl)vinyl]-1H-indole
C19H18N2O4
Acta Crystallographica Section E (2003) 59, 5 o672-o674
a=7.5949(4)Å b=10.0887(6)Å c=11.5777(7)Å
α=85.2980(10)° β=76.9240(10)° γ=86.1660(10)°
1,4-Bis{2-hydroxy-3-[N-(2-hydroxyethyl)imino]-5-methylbenzyl}piperazine
C26H36N4O4
Acta Crystallographica Section E (2003) 59, 1 o83-o85
a=9.7575(2)Å b=13.8091(3)Å c=18.42700(10)Å
α=90.00° β=99.9640(10)° γ=90.00°
N,N-Dimethyl-N'-phenylformamidinium perchlorate
C9H13N2ClO4
Acta Crystallographica Section E (2003) 59, 5 o662-o664
a=7.8382(2)Å b=17.5688(6)Å c=9.1123(2)Å
α=90.00° β=113.2690(10)° γ=90.00°
6a,14a-cis-6,6a,7,14a-Tetrahydrochromeno[4',3':3,4]pyrano[3,2-c]coumarin
C19H14O4
Acta Crystallographica Section E (2003) 59, 9 o1395-o1397
a=12.22520(10)Å b=16.3351(3)Å c=15.3425(3)Å
α=90.00° β=109.2070(10)° γ=90.00°
3-[2-(2,4-Dichlorophenyl)vinyl]-2-methyl-1-phenylsulfonyl-1H-indole
C23H17Cl2NO2S
Acta Crystallographica Section E (2003) 59, 5 o703-o705
a=8.00830(10)Å b=11.7242(2)Å c=21.9150(4)Å
α=86.4740(10)° β=89.8310(10)° γ=81.0370(10)°
1,2,3,4,4a,12a-Hexahydro-2,5,5-trimethyl-1-H-[2]benzopyrano[3,2-c]coumarin
C19H22O3
Acta Crystallographica Section E (2003) 59, 6 o808-o809
a=8.8291(4)Å b=9.8819(4)Å c=18.2053(8)Å
α=90.00° β=90.00° γ=90.00°
[6a,16b]-cis-7,7-Dimethyl-6,6a,7,16b- tetrahydrochromeno[4,3':3,4]pyrano[3,2-c]-α-naphthocoumarin
C25H20O4
Acta Crystallographica Section E (2003) 59, 5 o667-o669
a=12.1720(10)Å b=9.1400(10)Å c=18.0810(10)Å
α=90.00° β=106.580(10)° γ=90.00°
3-phenyl-4a,5-dihydro-1,2,4-triazolo[3,4-b][1,3]benzothiazine
C15H11N3S
Acta Crystallographica Section E (2003) 59, 5 o622-o624
a=11.5674(15)Å b=10.1948(19)Å c=21.433(3)Å
α=90.00° β=90.00° γ=90.00°
3,4:9,10-dibenzo-1,12-diformyl-5,8-dioxododecane
C16H14O4
Acta Crystallographica Section E (2003) 59, 6 o806-o807
a=7.7956(7)Å b=8.4511(8)Å c=11.4697(11)Å
α=83.054(2)° β=75.008(2)° γ=67.219(2)°
3-(1-Phenylsulfonyl-2-methylindol-3-ylcarbonyl)propanoic acid
C19H17NO5S
Acta Crystallographica Section E (2003) 59, 6 o875-o877
a=8.1825(2)Å b=9.97580(10)Å c=12.31210(10)Å
α=69.2810(10)° β=72.0670(10)° γ=70.8780(10)°
10-Benzyl-3,3,6,6,9-pentamethyl-3,4,6,7,9,10-hexahydroacridine- 1,8(2H,5H)-dione
C25H31NO2
Acta Crystallographica Section E (2005) 61, 8 o2761-o2763
a=10.33590(10)Å b=13.8339(3)Å c=16.2254(4)Å
α=101.1530(10)° β=90.9340(10)° γ=108.6870(10)°
3-Chloro-3-(9-ethyl-6-methyl-9H-carbazol-3-yl)propenal
C18H16ClNO
Acta Crystallographica Section E (2003) 59, 9 o1432-o1434
a=7.3191(7)Å b=8.9264(9)Å c=12.2024(12)Å
α=105.247(2)° β=91.771(2)° γ=104.378(2)°
2-Benzoyl-3-cyclohexyl-4-(p-methoxyphenyl)-5-phenylpyrrolidine-3-spiro- 3'-chroman-4'-one
C38H37NO4
Acta Crystallographica Section E (2003) 59, 10 o1572-o1574
a=11.8945(3)Å b=19.2698(4)Å c=27.0279(6)Å
α=90.00° β=90.00° γ=90.00°
1,2,3-Trimethoxy-5,11-dihydroindolo[1,2-b]isoquinoline-5,11-dione
C19H15NO5
Acta Crystallographica Section C (2005) 61, 12 o715-o717
a=20.8934(4)Å b=14.2400(3)Å c=22.8886(4)Å
α=90.00° β=110.0140(10)° γ=90.00°
2-Cyano-3-dimethylamino-N-(4-methylphenyl) acrylamide
C13H15N3O
Acta Crystallographica Section C (2003) 59, 7 o394-o396
a=7.5846(3)Å b=22.4477(10)Å c=7.5989(3)Å
α=90.00° β=106.3060(10)° γ=90.00°
2-cyano-3-dimethylamino-N-(2-methoxyphenyl) acrylamide
C13H15N3O2
Acta Crystallographica Section C (2003) 59, 7 o394-o396
a=7.5141(3)Å b=12.7580(6)Å c=13.9381(6)Å
α=90.00° β=92.7950(10)° γ=90.00°